跳至主要内容
临床试验/IRCT20191106045356N6
IRCT20191106045356N6已完成3 期

The effect of curcumin on the prevention of paclitaxel and platinum compounds-induced neuropathy in cancer patients: a randomized double-blinded controlled clinical trial

Yazd University of Medical Sciences0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 50 years(—)
性别
All

入选标准

  • Age 20-50 years
  • Initiation of the treatment with paclitaxel and platinum compounds in cancer patients

排除标准

  • History of allergy to curcumin or turmeric
  • Having diseases that cause neuropathy such as diabetes or conditions such as alcoholism.

研究者

发起方
Yazd University of Medical Sciences

相似试验